Seres Therapeutics, Inc. Inventory Write-down
Seres Therapeutics, Inc. (MCRB) reported Inventory Write-down of $0 for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2024-08-15
- Seres Therapeutics, Inc. inventory write-down for the quarter ending 2024-06-30 was $0.00.
- Seres Therapeutics, Inc. inventory write-down for the quarter ending 2024-03-31 was $0.00.
- Seres Therapeutics, Inc. inventory write-down for the quarter ending 2023-12-31 was $0.00.
- Seres Therapeutics, Inc. inventory write-down for the quarter ending 2023-09-30 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2024-08-15 | $0.00 derived: sum of 4 quarters · filed 2024-08-15 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-08-15 | $0.00 derived: sum of 3 quarters · filed 2024-08-15 | $0.00 derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-15 | $0.00 derived: sum of 2 quarters · filed 2024-08-15 | $0.00 derived: sum of 3 quarters · filed 2024-08-15 | $0.00 8-K · filed 2024-08-15 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |